ifosfamide has been researched along with AIDS-Associated Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, Y | 1 |
| Hagiwara, S | 1 |
| Uehira, T | 1 |
| Ajisawa, A | 1 |
| Kitanaka, A | 1 |
| Tanuma, J | 1 |
| Okada, S | 1 |
| Nagai, H | 1 |
| Glezerman, IG | 1 |
| Wang, ES | 1 |
| Straus, DJ | 1 |
| Teruya-Feldstein, J | 1 |
| Qin, J | 1 |
| Portlock, C | 1 |
| Moskowitz, C | 1 |
| Goy, A | 1 |
| Hedrick, E | 1 |
| Zelenetz, AD | 1 |
| Noy, A | 1 |
| Waddington, TW | 1 |
| Aboulafia, DM | 1 |
| Oriol, A | 1 |
| Ribera, JM | 1 |
| Brunet, S | 1 |
| del Potro, E | 1 |
| Abella, E | 1 |
| Esteve, J | 1 |
| Larson, ML | 1 |
| Enschede, SH | 1 |
| Gregory, SA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258] | Phase 4 | 50 participants (Anticipated) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifosfamide and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
HIV-related lymphoma treated with maintenance thalidomide.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine | 2005 |
5 other studies available for ifosfamide and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents, Alkylating; Antineoplastic | 2009 |
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabin | 2003 |
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral T | 2004 |
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ant | 2005 |